Publications on the project |
066 Iron nanoparticles' effectiveness for new antianemic preparations development |
Authors: | Rieznichenko L., Doroshenko A., Gruzina T., Dybkova S., Polova Z., Ulberg Z., Chekman I. | |
Summary: | | |
Keywords: | | |
Edition: | Conference Proceedings 5th International Conference NANOCON-2013, October 16-18, Brno, Czech Republic, EU | | | 2013,
556-560 ,English |
066 Synthesis of iron nanoparticles and characteristic of their biosafety |
Authors: | Rieznichenko L.S., Dybkova S.M., Doroshenko A.M., Chekman I.S., Ulberg Z.R. | |
Summary: | | |
Keywords: | | |
Edition: | Visnyk of problems in biology and medicine | | | 2014,
319-323,Ukrainian |
066 Estimation of biosafety of iron nanoparticles substance in vitro and in vivo |
Authors: | Rieznichenko L., Doroshenko A., Dybkova S., Gruzina T., Ulberg Z., Chekman I. | |
Summary: | | |
Keywords: | | |
Edition: | | | | 2014,
59-62,Ukrainian |
066 Antianemic activity of iron nanoparticles' substance under conditions of oral administration to rats |
Authors: | Doroshenko A.,Rieznichenko L., Dybkova S., Gruzina T., Maranov A.O., Ulberg Z., Chekman I. | |
Summary: | | |
Keywords: | | |
Edition: | Pharmacology and drug toxicology (Ukr) | | | 2014,
12-19,Ukrainian |
066 Influence of iron nanoparticles on intestinal microflora of rats with iron deficiency anemia |
Authors: | Doroshenko A., Rieznichenko L., Dybkova S., Gruzina T., Ulberg Z., Chekman I. | |
Summary: | | |
Keywords: | | |
Edition: | | | | 2014,
292-299,Ukrainian |
The events in the framework of the project |
066 066 066 066 066 066 066 066 066
|
066 2.4. Colloidal nanoscale systems Purpose:Decision of actual problem of modern medicine: development and creation of high effective antianemia preparation of new generation based on iron nanoparticles for prophylaxis and treatment of iron deficiency anemia and anemia of chronic diseases Expected results:Release of new product: material Stage 1:- Stage 2:- Stage 3:Synthesis of iron nanoparticles with different size and their physico-chemical characteristic
Stage 4:Assessment of therapeutic efficacy and therapeutic safety of iron nanoparticles in models of iron deficiency anemia and anemia of chronic disease Stage 5:Development of Technical orders for manufacturing of antianemic preparation based on iron nanoparticles for prophylaxis and treatment of iron deficiency anemia and anemia of chronic diseases
|